Soco, Ozia Samuel George M.
HRN: 22-33-48 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
MUPIROCIN 2%, 15G (TUBE)
12/26/2022
01/01/2023
DERMAL
-
TID
Omphalitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes